Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
P.A. Gross, A.W. Hermogenes, H.S. Sacks, J. Lau, R.A. Levandowski.
The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.
Ann Intern Med, 123 (1995), pp. 518-527
[2.]
Anónimo.
Drugs for non-HIV viral infections.
The Medical Letter, 41 (1999), pp. 113-120
[3.]
F.G. Hayden, A. Osterhaus, J.J. Treanor, D.M. Fleming, F.Y. Aoki, K.G. Nicholson, et al.
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections.
N Engl J Med, 337 (1997), pp. 874-880
[4.]
Anónimo.
Two neuraminidase inhibitors for treatment of influenza.
The Medical Letter, 41 (1999), pp. 91-93
[5.]
The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections.
Lancet, 352 (1998), pp. 1877-1881
[6.]
A.S. Monto, D.M. Fleming, D. Henry, R. De Groot, M. Makela, T. Klein, et al.
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections.
J Infect Dis, 180 (1999), pp. 254-261
[7.]
J.J. Treanor, F.G. Hayden, P.S. Vrooman, R. Barbarash, R. Bettis, D. Riff, et al.
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza. A randomized controlled trial.
JAMA, 283 (2000), pp. 1016-1024
[8.]
A.S. Monto, D.P. Robinson, M.L. Herlocher, J.M. Hinson Jr, M.J. Elliot, A. Crisp.
Zanamivir in the prevention of influenza among healthy adults. A randomized controlled trial.
JAMA, 282 (1999), pp. 31-35
[9.]
F.G. Hayden, R.L. Atmar, M. Schilling, C. Johnson, D. Poretz, D. Para, et al.
Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
N Engl J Med, 341 (1999), pp. 1336-1343
Copyright © 2000. Elsevier España, S.L.. Todos los derechos reservados
